Candel Therapeutics CADL
NASDAQ CADL
$10.19 +0.03 (+0.34%)
As of: Oct 2, 2026 · 10:59 AM EDT

Candel Therapeutics (CADL) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Candel Therapeutics (CADL) posted Liabilities and Shareholders Equity of $208.15 million for Q2 2026, up 96.4% from $105.97 million a year earlier.

Analysis

Candel Therapeutics (CADL) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Candel Therapeutics' Liabilities and Shareholders Equity came in at $125.2 million, up 17.2% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 26.7% (FY2020 to FY2025).
  • In prior years, Candel Therapeutics' Liabilities and Shareholders Equity was $106.87 million in FY2024 (+159.4%), $41.2 million in FY2023 (-47.0%), $77.69 million in FY2022 (-12.9%) and $89.21 million in FY2021 (+133.0%).
  • The Q2 2026 figure stands as the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2020.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in six of the last seven quarters, with growth averaging 151.2%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q3 2025, with growth of 335.0%; the weakest was Q3 2024, with a decline of 57.0%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Candel Therapeutics 794.67 Mn 794.67 Mn - 208.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 208.15 Mn
Dec 31, 2025 125.20 Mn
Sep 30, 2025 93.60 Mn
Jun 30, 2025 105.97 Mn
Mar 31, 2025 95.91 Mn
Dec 31, 2024 106.87 Mn
Sep 30, 2024 21.52 Mn
Jun 30, 2024 26.49 Mn
Mar 31, 2024 31.22 Mn
Dec 31, 2023 41.20 Mn
Sep 30, 2023 50.06 Mn
Jun 30, 2023 58.71 Mn
Mar 31, 2023 67.24 Mn
Dec 31, 2022 77.69 Mn
Sep 30, 2022 85.01 Mn
Jun 30, 2022 93.30 Mn
Mar 31, 2022 101.56 Mn
Dec 31, 2021 89.21 Mn
Sep 30, 2021 95.96 Mn
Jun 30, 2021 30.74 Mn
API Access

Candel Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CADL&period=max&api_key=YOUR_API_KEY